+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadodiamide Market - Global Forecast 2026-2032- Product Image
Gadodiamide Market - Global Forecast 2026-2032- Product Image
Sale

Gadodiamide Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129140
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gadodiamide Market is projected to reach USD 440.55 Million in 2026. It is expected to continue growing at a CAGR of 2.83%, reaching USD 518.93 Million by 2032.

Gadodiamide: Clinical Role and Market Context

Gadodiamide is a gadolinium-based contrast agent used with magnetic resonance imaging to improve visualization of organs, tissues, and vascular structures. Its relevance is shaped by diagnostic imaging protocols, product labeling, institutional safety policies, and the evolving preference for contrast agents with well-characterized risk profiles. Clinical use requires appropriate patient selection, dose management, and attention to renal function and prior contrast reactions.

Safety Governance Is Reshaping Gadodiamide Use

The gadodiamide landscape has been transformed by stronger safeguards around gadolinium retention and nephrogenic systemic fibrosis. Regulatory communications, contraindications or restrictions for patients with severe renal impairment, updated informed-consent practices, and institutional preference for alternative agents have influenced utilization decisions. These changes have elevated the importance of traceability, pharmacovigilance, protocol standardization, and evidence-based selection by radiology teams.

Artificial Intelligence Improves Imaging Workflows, Not Clinical Judgment

Artificial intelligence is increasingly applied to scan prioritization, image reconstruction, motion correction, lesion detection, protocol optimization, and workflow coordination. In gadolinium-enhanced MRI, these tools may help reduce repeat examinations, support consistent image quality, and identify studies requiring expedited review. However, AI does not replace renal-risk assessment, contrast selection, administration safeguards, or radiologist interpretation; validated performance, human oversight, cybersecurity, and data governance remain essential.

Regional Insights: Regulation and Imaging Capacity Drive Adoption

North America emphasizes safety monitoring, institutional protocols, and advanced imaging workflow integration. Europe places strong weight on regulatory guidance, gadolinium-retention considerations, and coordinated clinical governance. Asia-Pacific combines expanding diagnostic capacity with varied regulatory and reimbursement environments, creating differing patterns of access and protocol adoption. Latin America is influenced by public-private capacity differences, procurement requirements, and availability of specialized MRI services. The Middle East is shaped by investment in tertiary healthcare, centralized procurement, and specialist expertise, while Africa faces uneven access to MRI infrastructure, trained personnel, maintenance support, and contrast-agent supply continuity.

Group Insights: Policy Alignment and Procurement Shape Practice

ASEAN markets reflect diverse healthcare systems and regulatory approaches, making local registration, supply reliability, and training important. BRICS countries combine substantial public-health needs with varied domestic manufacturing, procurement, and access conditions. The European Union benefits from shared regulatory structures while retaining national differences in reimbursement and hospital policy. G7 systems generally have mature MRI infrastructure, robust pharmacovigilance, and strong institutional controls. GCC countries emphasize centralized purchasing, specialist hospital networks, and technology-enabled care. NATO members span different health systems, but continuity of essential diagnostics, interoperability, and resilient procurement are common strategic concerns.

Country Insights: Differing Clinical and Regulatory Priorities

Australia and Canada emphasize evidence-based imaging governance across geographically dispersed systems. Brazil and Mexico balance growing diagnostic needs with public-sector procurement and uneven regional access. China and India combine large patient populations with expanding imaging capability, varied hospital resources, and evolving regulatory requirements. France, Germany, Italy, Spain, and the United Kingdom operate within highly structured healthcare environments, with national or regional guidance influencing contrast-agent selection and reimbursement. Japan and South Korea have advanced imaging ecosystems and strong quality controls. Russia’s environment is shaped by regulatory, procurement, and supply-chain conditions. The United States combines extensive MRI utilization with detailed institutional safety procedures, regulatory oversight, and payer-related operational considerations.

Action Priorities for Leaders in Gadodiamide-Related Care

Industry leaders should align product stewardship with current renal-safety guidance, retention evidence, labeling requirements, and local institutional protocols. They should strengthen supplier qualification, batch traceability, cold-chain or storage compliance where applicable, and contingency planning for shortages. Clinical organizations can improve outcomes through standardized screening, documented consent, adverse-event reporting, staff training, and periodic protocol review. Investment in interoperable imaging systems and carefully validated AI tools can reduce workflow friction while preserving radiologist oversight. Any use of gadodiamide should remain clinically justified and consistent with the approved product information and local regulations.

Research Methodology: Evidence-Based Executive Assessment

This executive summary uses a structured review framework focused on the clinical role of gadodiamide, safety governance, diagnostic-imaging workflows, regulatory considerations, and geographic healthcare-system characteristics. Findings should be validated against current product labeling, regulator communications, peer-reviewed clinical literature, professional-society guidance, hospital protocols, and publicly available procurement or access information. Regional, group, and country comparisons are qualitative and are intended to identify operational differences rather than quantify commercial performance. No market estimates, forecasts, shares, or sizing assumptions are used.

Conclusion: Safe, Protocol-Driven Use Remains Central

Gadodiamide remains relevant where contrast-enhanced MRI is clinically indicated, but its role is governed by increasingly rigorous safety and stewardship expectations. Differences in regulation, imaging capacity, procurement, and clinical infrastructure will continue to shape practice across regions and country groups. Leaders who combine evidence-based contrast selection, reliable supply processes, disciplined pharmacovigilance, and responsible digital innovation will be better positioned to support safe and effective diagnostic imaging.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gadodiamide Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Gadodiamide Market, by Dose Form
8.1. Introduction
8.2. Pre-Filled Syringes
8.3. Vials
9. Gadodiamide Market, by Application
9.1. Introduction
9.2. Body Imaging
9.2.1. Abdominal MRI
9.2.2. Breast MRI
9.2.3. Pelvic MRI
9.3. Cardiovascular Imaging
9.3.1. Cardiac MRI
9.3.2. Vascular Imaging
9.3.2.1. Arterial Imaging
9.3.2.2. Venous Imaging
9.4. Central Nervous System Imaging
9.4.1. Brain Imaging
9.4.2. Spinal Cord Imaging
9.5. Musculoskeletal Imaging
9.5.1. Bone Marrow Imaging
9.5.2. Joint Imaging
10. Gadodiamide Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.5. Hospitals
11. Gadodiamide Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Gadodiamide Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Gadodiamide Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AptarGroup
15.2. Aurobindo Pharma Limited
15.3. Bayer AG
15.4. Beckman Coulter
15.5. Bracco Imaging S.p.A.
15.6. Cadila Healthcare Limited
15.7. Cardinal Health
15.8. Dr. Reddy’s Laboratories Limited
15.9. Eisai Co., Ltd.
15.10. Fujifilm Holdings Corporation
15.11. GE HealthCare Technologies, Inc.
15.12. Guerbet Group
15.13. Hengrui Medicine Co., Ltd.
15.14. Lantheus Medical Imaging, Inc.
15.15. Linde plc
15.16. Litha Healthcare Group, Inc.
15.17. Mallinckrodt plc
15.18. Sagent Pharmaceuticals, Inc.
15.19. Sandoz International GmbH
15.20. Siemens Healthineers
15.21. Sun Pharmaceutical Industries Limited
15.22. Teva Pharmaceutical Industries Limited
15.23. Yamasa Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gadodiamide Market, Years Considered for the Study
FIGURE 2. Global Gadodiamide Market, Research Design
FIGURE 3. Global Gadodiamide Market, Research Framework
FIGURE 4. Global Gadodiamide Market, Data Triangulation
FIGURE 5. Global Gadodiamide Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gadodiamide Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gadodiamide Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gadodiamide Market Size, by Dose Form, 2025 vs 2032 (%)
FIGURE 9. Global Gadodiamide Market Size, by Dose Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gadodiamide Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Gadodiamide Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gadodiamide Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Gadodiamide Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gadodiamide Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Gadodiamide Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gadodiamide Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Gadodiamide Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Gadodiamide Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gadodiamide Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gadodiamide Market Segmentation & Coverage
TABLE 2. Global Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 11. Global Pre-Filled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Pre-Filled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Pre-Filled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 18. Global Body Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Body Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Body Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Abdominal MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Abdominal MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Abdominal MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Breast MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Breast MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Breast MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Pelvic MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Pelvic MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Pelvic MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Cardiovascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Cardiovascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Cardiovascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Cardiac MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Cardiac MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Cardiac MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Vascular Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Vascular Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Vascular Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Arterial Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Arterial Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Arterial Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Venous Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Venous Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Venous Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Central Nervous System Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Central Nervous System Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Central Nervous System Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Brain Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Brain Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Brain Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Spinal Cord Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Spinal Cord Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Spinal Cord Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Musculoskeletal Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Musculoskeletal Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Musculoskeletal Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Bone Marrow Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Bone Marrow Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Bone Marrow Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Joint Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Joint Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Joint Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. North America Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. North America Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. North America Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 90. North America Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. North America Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 92. North America Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 93. North America Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 94. North America Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 95. North America Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 96. North America Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Latin America Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Latin America Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Latin America Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 100. Latin America Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Latin America Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 102. Latin America Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 103. Latin America Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 104. Latin America Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 105. Latin America Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 106. Latin America Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Europe Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Europe Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. Europe Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 110. Europe Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. Europe Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 112. Europe Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 113. Europe Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 114. Europe Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 115. Europe Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 116. Europe Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Middle East Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Middle East Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. Middle East Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 120. Middle East Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Middle East Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 122. Middle East Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 123. Middle East Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 124. Middle East Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 125. Middle East Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 126. Middle East Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Africa Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Africa Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. Africa Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 130. Africa Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Africa Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 132. Africa Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 133. Africa Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 134. Africa Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 135. Africa Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 136. Africa Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Global Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. ASEAN Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 141. ASEAN Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. ASEAN Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 143. ASEAN Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 144. ASEAN Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 145. ASEAN Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 146. ASEAN Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 147. ASEAN Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. GCC Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. GCC Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. GCC Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 151. GCC Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. GCC Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 153. GCC Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 154. GCC Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 155. GCC Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 156. GCC Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 157. GCC Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. European Union Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. European Union Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. European Union Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 161. European Union Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. European Union Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 163. European Union Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 164. European Union Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 165. European Union Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 166. European Union Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 167. European Union Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. BRICS Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. BRICS Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. BRICS Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 171. BRICS Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. BRICS Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 173. BRICS Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 174. BRICS Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 175. BRICS Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 176. BRICS Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 177. BRICS Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. G7 Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. G7 Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 180. G7 Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 181. G7 Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. G7 Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 183. G7 Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 184. G7 Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 185. G7 Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 186. G7 Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 187. G7 Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. NATO Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. NATO Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. NATO Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 191. NATO Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. NATO Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 193. NATO Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 194. NATO Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 195. NATO Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 196. NATO Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 197. NATO Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Global Gadodiamide Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. United States Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 200. United States Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. United States Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 202. United States Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. United States Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 204. United States Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 205. United States Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 206. United States Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 207. United States Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 208. United States Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Canada Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 210. Canada Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Canada Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 212. Canada Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Canada Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 214. Canada Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 215. Canada Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 216. Canada Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 217. Canada Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 218. Canada Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Mexico Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 220. Mexico Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Mexico Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 222. Mexico Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. Mexico Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 224. Mexico Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 225. Mexico Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 226. Mexico Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 227. Mexico Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 228. Mexico Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Brazil Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 230. Brazil Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Brazil Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 232. Brazil Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Brazil Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 234. Brazil Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 235. Brazil Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 236. Brazil Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 237. Brazil Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 238. Brazil Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. United Kingdom Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 240. United Kingdom Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. United Kingdom Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 242. United Kingdom Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. United Kingdom Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 244. United Kingdom Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 245. United Kingdom Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 246. United Kingdom Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 247. United Kingdom Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 248. United Kingdom Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Germany Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 250. Germany Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. Germany Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 252. Germany Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Germany Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 254. Germany Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 255. Germany Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 256. Germany Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 257. Germany Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 258. Germany Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. France Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 260. France Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. France Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 262. France Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. France Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 264. France Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 265. France Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 266. France Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 267. France Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 268. France Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Russia Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 270. Russia Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Russia Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 272. Russia Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Russia Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 274. Russia Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 275. Russia Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 276. Russia Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 277. Russia Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 278. Russia Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Italy Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 280. Italy Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. Italy Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 282. Italy Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Italy Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 284. Italy Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 285. Italy Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 286. Italy Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 287. Italy Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 288. Italy Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Spain Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 290. Spain Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. Spain Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 292. Spain Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. Spain Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 294. Spain Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 295. Spain Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 296. Spain Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 297. Spain Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 298. Spain Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. China Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 300. China Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 301. China Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 302. China Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 303. China Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 304. China Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 305. China Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 306. China Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 307. China Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 308. China Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. India Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 310. India Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 311. India Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 312. India Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. India Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 314. India Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 315. India Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 316. India Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 317. India Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 318. India Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Japan Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 320. Japan Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Japan Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 322. Japan Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 323. Japan Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 324. Japan Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 325. Japan Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 326. Japan Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 327. Japan Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 328. Japan Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. Australia Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 330. Australia Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 331. Australia Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 332. Australia Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 333. Australia Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 334. Australia Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 335. Australia Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 336. Australia Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 337. Australia Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 338. Australia Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. South Korea Gadodiamide Market Size, 2017-2032 (USD Million)
TABLE 340. South Korea Gadodiamide Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 341. South Korea Gadodiamide Market Size, by Dose Form, 2017-2032 (USD Million)
TABLE 342. South Korea Gadodiamide Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. South Korea Gadodiamide Market Size, by Body Imaging, 2017-2032 (USD Million)
TABLE 344. South Korea Gadodiamide Market Size, by Cardiovascular Imaging, 2017-2032 (USD Million)
TABLE 345. South Korea Gadodiamide Market Size, by Vascular Imaging, 2017-2032 (USD Million)
TABLE 346. South Korea Gadodiamide Market Size, by Central Nervous System Imaging, 2017-2032 (USD Million)
TABLE 347. South Korea Gadodiamide Market Size, by Musculoskeletal Imaging, 2017-2032 (USD Million)
TABLE 348. South Korea Gadodiamide Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. Global Gadodiamide Market Share, by Key Player, 2025
TABLE 350. Global Gadodiamide Market, Key Experts

Companies Mentioned

  • AptarGroup
  • Aurobindo Pharma Limited
  • Bayer AG
  • Beckman Coulter
  • Bracco Imaging S.p.A.
  • Cadila Healthcare Limited
  • Cardinal Health
  • Dr. Reddy’s Laboratories Limited
  • Eisai Co., Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guerbet Group
  • Hengrui Medicine Co., Ltd.
  • Lantheus Medical Imaging, Inc.
  • Linde plc
  • Litha Healthcare Group, Inc.
  • Mallinckrodt plc
  • Sagent Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Siemens Healthineers
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Yamasa Corporation

Related Topics

Related Reports

Gadolinium Contrast Media Market - Global Forecast 2026-2032 - Product Image

Gadolinium Contrast Media Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
MRI Contrast Media Market Report 2026 - Product Image

MRI Contrast Media Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Gadopentetate Dimeglumine Market - Global Forecast 2026-2032 - Product Image

Gadopentetate Dimeglumine Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Contrast Media Injectors - Global Strategic Business Report - Product Image

Contrast Media Injectors - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Contrast Delivery System Market Analysis: Dynamics, Technological Innovations, and Competitive Landscape (2026-2031) - Product Image

Contrast Delivery System Market Analysis: Dynamics, Technological Innovations, and Competitive Landscape (2026-2031)

  • Report
  • 105 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.